Cargando…
Strategies to engage lost to follow-up patients with phenylketonuria in the United States: Best practice recommendations
BACKGROUND: Phenylketonuria (PKU) is a rare autosomal recessive disorder caused by mutations in the gene encoding phenylalanine hydroxylase, an enzyme that converts phenylalanine to tyrosine. Untreated, PKU is characterized by a range of neuropsychological and neurocognitive impairments. Due to ubiq...
Autores principales: | Beazer, Jennifer, Breck, Jane, Eggerding, Caroline, Gordon, Patricia, Hacker, Stephanie, Thompson, Amie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044524/ https://www.ncbi.nlm.nih.gov/pubmed/32140415 http://dx.doi.org/10.1016/j.ymgmr.2020.100571 |
Ejemplares similares
-
Use of pegvaliase in the management of phenylketonuria: Case series of early experience in US clinics()
por: Adams, Darius, et al.
Publicado: (2021) -
Evidence- and consensus-based recommendations for the use of
pegvaliase in adults with phenylketonuria
por: Longo, Nicola, et al.
Publicado: (2018) -
Phenylketonuria
por: Hudson, Frederick
Publicado: (1969) -
The financial and time burden associated with phenylketonuria treatment in the United States
por: Rose, Angela M., et al.
Publicado: (2019) -
LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact
por: Akl, Elie A, et al.
Publicado: (2009)